Granules India Ltd (GRANULES) Financial Research

Granules India is a vertically integrated pharmaceutical manufacturer that produces Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and finished dosage forms, allowing it to control the supply chain from raw materials to final products. The company’s scale in key molecules like paracetamol and ibuprofen, combined with its backward integration, positions it as a cost-competitive supplier to both regulated and emerging markets. Its business model focuses on high-volume, non-innovator drugs, serving as a reliable partner for generic drug makers and global distributors.

Current Price: INR 604.0

Price Change: -1.43%

None